HDAC8 and glioblastoma: An inhibitor of HDAC8 combined with temozolomide administration induced WT-p53-mediated apoptosis via WT-p53-mediated O-methylguanine-DNA methyltransferase inhibition in GBM-R cell lines (Tsai et al., 2021).